Method for In Vivo Evaluation of Cytokines of an Alternate, Novel Gene Therapy-Derived IL-17 Stimulates Granulopoiesis in Mice: Use

[1]  Yulan He,et al.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. , 1998, Journal of immunology.

[2]  J. Lancaster,et al.  Activation of alveolar macrophages and lung host defenses using transfer of the interferon-gamma gene. , 1997, The American journal of physiology.

[3]  W. Sly,et al.  Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Volk,et al.  Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. , 1996, Human gene therapy.

[5]  J. Banchereau,et al.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.

[6]  H. Broxmeyer.  Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? , 1996, The Journal of experimental medicine.

[7]  J. Shellito,et al.  Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors. , 1996, Human gene therapy.

[8]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.

[9]  J. Schaack,et al.  Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase , 1995, Journal of virology.

[10]  H. Ertl,et al.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.

[11]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Beutler,et al.  Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Zsebo,et al.  Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo. , 1991, Blood.

[14]  D. Remick,et al.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. , 1991, Journal of immunology.

[15]  T. Miyawaki,et al.  Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro. , 1990, Experimental hematology.

[16]  T. Dexter,et al.  A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. , 1990, Blood.

[17]  H. Ishibashi,et al.  Induction of polymorphonuclear leukocyte-derived hepatocyte stimulating factor and effects on alpha 2-macroglobulin synthesis. , 1989, Journal of clinical & laboratory immunology.

[18]  W P Sheridan,et al.  Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor. , 1989, Blood.

[19]  A. van der Eb,et al.  Transformation of rat cells by DNA of human adenovirus 5. , 1973, Virology.